<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document SYSTEM "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP1531833A1" country="EP" dtd-version="ep-patent-document-v1-4.dtd" doc-number="1531833" date-publ="20050525" file="03738866.7" lang="en" kind="A1" status="n"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHU..SK................</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>DIM350 (Ver 2.1 Jan 2001) 1100000/0 1710000/0</B007EP></eptags></B000><B100><B110>1531833</B110><B130>A1</B130><B140><date>20050525</date></B140><B190>EP</B190></B100><B200><B210>03738866.7</B210><B220><date>20030717</date></B220><B240><B241><date>20041227</date></B241></B240><B250>En</B250><B251EP>En</B251EP><B260>En</B260></B200><B300><B310>0202253</B310><B320><date>20020718</date></B320><B330><ctry>SE</ctry></B330><B310>407680 P</B310><B320><date>20020904</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20050525</date><bnum>200521</bnum></B405><B430><date>20050525</date><bnum>200521</bnum></B430></B400><B500><B510><B516>7</B516><B511> 7A 61K  31/7088 A</B511><B512> 7A 61K  48/00   B</B512><B512> 7A 61P  11/06   B</B512><B512> 7A 61P  17/06   B</B512><B512> 7A 61P  11/00   B</B512><B512> 7A 61P  19/02   B</B512><B512> 7A 61P   1/04   B</B512><B512> 7A 61P   1/00   B</B512><B512> 7C 12N  15/11   B</B512><B514> 7C 12N   9/64   J</B514><B514> 7C 12N   9:66   J</B514><B517EP> // (C12N9/64, 9:66)</B517EP></B510><B540><B541>de</B541><B542>ANTISENSE-VERBINDUNGEN, VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON ENTZ NDLICHEN ERKRANKUNGEN IM ZUSAMMENHANG MIT MMP-12</B542><B541>en</B541><B542>ANTISENSE COMPOUNDS, METHODS AND COMPOSITIONS FOR TREATING MMP-12 RELATED INFLAMMATORY DISORDERS</B542><B541>fr</B541><B542>COMPOSES ANTISENS, PROCEDES ET COMPOSITIONS POUR LE TRAITEMENT DE TROUBLES INFLAMMATOIRES LIES A LA METALLOPROTEINASE MATRICIELLE-12 (MMP-12)</B542></B540></B500><B700><B710><B711><snm>Index Pharmaceuticals AB</snm><iid>03302642</iid><irf>AH 53756 inl</irf><adr><str>Fogdevreten 2A</str><city>171 77 Stockholm</city><ctry>SE</ctry></adr></B711></B710><B720><B721><snm>DIECKMANN, Andreas</snm><adr><str>Margaretelundsvägen 76</str><city>S-167 36 Bromma</city><ctry>SE</ctry></adr></B721><B721><snm>LÖFBERG, Robert</snm><adr><str>Ekebyvägen 9</str><city>S-182 55 Djursholm</city><ctry>SE</ctry></adr></B721><B721><snm>VON STEIN, Oliver</snm><adr><str>B tman Stens väg 23</str><city>S-163 41 Sp nga</city><ctry>SE</ctry></adr></B721><B721><snm>VON STEIN, Petra</snm><adr><str>B tman Stens väg 23</str><city>S-163 41 Sp nga</city><ctry>SE</ctry></adr></B721><B721><snm>GOOD, Liam</snm><adr><str>Teknologgatan 9B, 2 tr</str><city>SE-113 60 Stockholm</city><ctry>SE</ctry></adr></B721></B720><B740><B741><snm>Holmberg, Martin</snm><sfx>et al</sfx><iid>00099021</iid><adr><str>Bergenstrahle &amp; Lindvall ABP.O. Box 17704</str><city>118 93 Stockholm</city><ctry>SE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>AL</ctry></B845EP><B845EP><ctry>LT</ctry></B845EP><B845EP><ctry>LV</ctry></B845EP><B845EP><ctry>MK</ctry></B845EP></B844EP><B860><B861><dnum><anum>SE2003001223</anum></dnum><date>20030717</date></B861><B862>En</B862></B860><B870><B871><dnum><pnum>WO2004009098</pnum></dnum><date>20040129</date><bnum>200405</bnum></B871></B870></B800></SDOBI></ep-patent-document>
